University of Ljubljana

About: University of Ljubljana is a education organization based out in Ljubljana, Slovenia. It is known for research contribution in the topics: Population & Liquid crystal. The organization has 17210 authors who have published 47013 publications receiving 1082684 citations. The organization is also known as: Univerza v Ljubljani.

Measurement of baryon acoustic oscillations in the Lyman-α forest fluctuations in BOSS data release 9

Abstract: We use the Baryon Oscillation Spectroscopic Survey (BOSS) Data Release 9 (DR9) to detect and measure the position of the Baryonic Acoustic Oscillation (BAO) feature in the three-dimensional correlation function in the Lyman-α flux fluctuations at a redshift zeff = 2.4. The feature is clearly detected at significance between 3 and 5 sigma (depending on the broadband model and method of error covariance matrix estimation) and is consistent with predictions of the standard ΛCDM model. We assess the biases in our method, stability of the error covariance matrix and possible systematic effects. We fit the resulting correlation function with several models that decouple the broadband and acoustic scale information. For an isotropic dilation factor, we measure 100 × (αiso − 1) = −1.6+2.0 +4.3 +7.4−2.0 −4.1 −6.8 (stat.) ±1.0 (syst.) (multiple statistical errors denote 1,2 and 3 sigma confidence limits) with respect to the acoustic scale in the fiducial cosmological model (flat ΛCDM with Ωm = 0.27, h = 0.7). When fitting separately for the radial and transversal dilation factors we find marginalised constraints 100 × (α|| − 1) = −1.3+3.5 +7.6 +12.3−3.3 −6.7 −10.2 (stat.) ±2.0 (syst.) and 100 × (α⊥ − 1) = −2.2+7.4 +17−7.1 −15 (stat.) ±3.0 (syst.). The dilation factor measurements are significantly correlated with cross-correlation coefficient of ~ −0.55. Errors become significantly non-Gaussian for deviations over 3 standard deviations from best fit value. Because of the data cuts and analysis method, these measurements give tighter constraints than a previous BAO analysis of the BOSS DR9 Lyman-α sample, providing an important consistency test of the standard cosmological model in a new redshift regime.

Suitability of close-to-nature silviculture for adapting temperate European forests to climate change

Abstract: In many parts of Europe, close-to-nature silviculture (CNS) has been widely advocated as being the best approach for managing forests to cope with future climate change. In this review, we identify and evaluate six principles for enhancing the adaptive capacity of European temperate forests in a changing climate: (1) increase tree species richness, (2) increase structural diversity, (3) maintain and increase genetic variation within tree species, (4) increase resistance of individual trees to biotic and abiotic stress, (5) replace high-risk stands and (6) keep average growing stocks low. We use these principles to examine how three CNS systems (single-tree selection, group selection and shelterwood) serve adaptation strategies. Many attributes of CNS can increase the adaptive capacity of European temperate forests to a changing climate. CNS promotes structural diversity and tree resistance to stressors, and growing stocks can be kept at low levels. However, some deficiencies exist in relation to the adaptation principles of increasing tree species richness, maintaining and increasing genetic variation, and replacing high-risk stands. To address these shortcomings, CNS should make increased use of a range of regeneration methods, in order to promote light-demanding tree species, non-native species and non-local provenances.

Electrochemotherapy: from the drawing board into medical practice

Abstract: Electrochemotherapy is a local treatment of cancer employing electric pulses to improve transmembrane transfer of cytotoxic drugs. In this paper we discuss electrochemotherapy from the perspective of biomedical engineering and review the steps needed to move such a treatment from initial prototypes into clinical practice. In the paper also basic theory of electrochemotherapy and preclinical studies in vitro and in vivo are briefly reviewed. Following this we present a short review of recent clinical publications and discuss implementation of electrochemotherapy into standard of care for treatment of skin tumors, and use of electrochemotherapy for other targets such as head and neck cancer, deep-seated tumors in the liver and intestinal tract, and brain metastases. Electrodes used in these specific cases are presented with their typical voltage amplitudes used in electrochemotherapy. Finally, key points on what should be investigated in the future are presented and discussed.